Quantification of rivaroxaban in marketed tablets and prepared NPs formulations (n = 3).
| Samples | Theoretical content (mg) | Content found (ng) ± SD | Content (%) |
|---|---|---|---|
| Marketed tablets | 10 | 9.92 ± 0.86 | 99.20 |
| NPs | 10 | 9.80 ± 1.07 | 98.08 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.